Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 20, 2023
Dr. Fred Appelbaum receives Lifetime Achievement award
Medical pioneer and longtime Fred Hutch leader honored by American Society for Transplantation and Cellular Therapy
Fred Hutch hosts inaugural Dr. E. Donnall Thomas Symposium
Event draws leading researchers in transplantation, gene and cell therapy
Pushing science forward while working from home
As COVID-19 forces research labs to drastically reduce on-site operations, scientists figure out how to advance their work and stay connected
Landmark scientific paper turns 40
First unequivocal proof in humans of immune cells’ cancer-curing power laid the groundwork for cancer immunotherapy, modern bone marrow transplantation
Dr. Robert Hickman, inventor of Hickman catheter, dies at age 92
Lifesaving device was ‘a gift to the world,’ former colleagues say
How a phone call helped shape the field of bone marrow transplant
A lifesaving new leukemia treatment was harming some patients’ digestive organs, and no one really understood why. So, over 40 years, Dr. George McDonald helped fill in the gaps.
Dr. Geoffrey Hill 3rd recipient of José Carreras/E. Donnall Thomas Endowed Chair for Cancer Research
Endowments provide faculty with freedom and flexibility to pursue critical research endeavors
Science without borders
At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases
‘A place where miracles happen’: Opening of Bezos Family Immunotherapy Clinic highlights patient-focused science
Research symposium and ribbon cutting celebrates first-of-its-kind facility for experimental immunotherapies
Three's a charm in a triple-drug combination for transplant patients
A drug with a storied past offers a new edge against an old foe
Good News: Dr. David Maloney named cellular immunotherapy medical director at Fred Hutch, SCCA; Dr. Jim Kublin gets grant to study how gut bugs alter HIV vaccine response
Celebrating faculty and staff achievements
When do we say cure for cancer?
A loaded word for cancer patients, but researchers view ‘cure’ through lens of statistics
Good News at Fred Hutch: Immunotherapy pioneer named chair, Nobel laureate keynotes
Celebrating faculty and staff achievements
A life in tune
Erlinda Santos balances science and song after more than four decades at Fred Hutch
Kids like Rita: A doctor’s drive to save children from deadly blood cancers
Pediatric transplant pioneer Dr. Jean Sanders reflects on a lifetime of dedicated focus, all for ‘her kids’
From building toys to developing cures
At 80, transplant scientist Dr. Rainer Storb can't stop tinkering with — and solving — medical puzzles
Grateful survivors gather at BMT reunion
Nearly 200 former patients attend seventh Bone Marrow Transplant Survivor Reunion at Fred Hutch
Good News at Fred Hutch
<p>Dr. Rainer Storb receives $12.9M to study blood stem-cell therapies for immune deficiencies; Dr. Julie Overbaugh studies HIV 'superinfection' to provide clues for better vaccine design</p>
Fred Hutch researcher Rainer Storb receives $12.9 million to study immunotherapies, gene therapies to improve treatments for sickle-cell anemia, “bubble boy” disease and related conditions
Research to improve treatments for sickle-cell anemia, “bubble boy” disease and related conditions
Fred Hutch researcher Rainer Storb named a Fellow of the American Association for the Advancement of Science
Storb noted for his contributions to the field of bone marrow transplantation